C.F.R. homeSearch C.F.R.
C.F.R.Title 21Chapter I—Food and Drug Administration, Department of Health and Human ServicesSubchapter A—GeneralPart 20—Public InformationSubpart A—Official Testimony and Information

21 C.F.R. § 20.1 (2026)

Testimony by Food and Drug Administration employees

Edition and currency
eCFR text as of Sept. 29, 2026. The text is the edition Syfert holds; for a past event, check the version in force on that date.
Other sources
CURRENTeCFR text as of Sept. 29, 2026 cited 1965–2024 16citing cases
At a glance

Courts have cited this section in 16 opinions since 1965, 2 of them in the last five years.

(a) No officer or employee of the Food and Drug Administration or of any other office or establishment in the Department of Health and Human Services, except as authorized by the Commissioner of Food and Drugs pursuant to this section or in the discharge of his official duties under the laws administered by the Food and Drug Administration, shall give any testimony before any tribunal pertaining to any function of the Food and Drug Administration or with respect to any information acquired in the discharge of his official duties.

(b) Whenever a subpoena, in appropriate form, has been lawfully served upon an officer or employee of the Food and Drug Administration commanding the giving of any testimony, such officer or employee shall, unless otherwise authorized by the Commissioner, appear in response thereto and respectfully decline to testify on the grounds that it is prohibited by this section.

(c) A person who desires testimony from any employee may make written request therefor, verified by oath, directed to the Commissioner setting forth his interest in the matter sought to be disclosed and designating the use to which such testimony will be put in the event of compliance with such request: Provided, That a written request therefor made by a health, food, or drug officer, prosecuting attorney, or member of the judiciary of any State, Territory, or political subdivision thereof, acting in his official capacity, need not be verified by oath. If it is determined by the Commissioner, or any other officer or employee of the Food and Drug Administration whom he may designate to act on his behalf for the purpose, that such testimony will be in the public interest and will promote the objectives of the act and the agency, the request may be granted. Where a request for testimony is granted, one or more employees of the Food and Drug Administration may be designated to appear, in response to a subpoena, and testify with respect thereto.

The 16 cases that cite 21 C.F.R. § 20.1 most heavily, weighted by court and treatment. RelevanceNewestTreatment
cites § 20.1 4×cited by 36 cases
Where it cites § 20.1
“Archer and Page to testify in depositions for the pending MDL proceedings, pursuant to 21 C.F.R. § 20.1 . More specifically, the plaintiff sought their testimony regarding Dr.”
Later courts cite it for
“without question, a foia respondent has a duty to release legible, complete records.” · 3 citing courts
2
GREENFrank v. United States Food & Drugs Admin., 998 F. Supp. 2d 596 (E.D. Mich. 2014).
cites § 20.1 12×cited by 2 cases
Where it cites § 20.1
“The FDA responded by denying the requests on the bases of both 21 C.F.R. § 20.1 and the principles of sovereign immunity protecting federal agencies from being compelled by state courts to produce employee testimony or records.”
3
GREENSubpoenas in Sec. & Exch. Comm'n v. Selden, 484 F. Supp. 2d 105 (D.D.C. 2007).
cites § 20.1 5×cited by 4 cases
Where it cites § 20.1
“(citing 21 C.F.R. § 20.1 ). The FDA’s argument in this regard is unfounded.”
4
GREENSusan & Andrew Giza v. Sec'y of Health, 628 F.2d 748 (1st Cir. 1980).
cites § 20.1 1×cited by 39 cases
Where it cites § 20.1
“3 The district court stated that heads of federal agencies have authority to restrict testimony by their subordinates and that such had been done in this case pursuant to an FDA regulation.”
The case’s holding
A district court lacks authority under the Freedom of Information Act to compel an agency to generate explanatory material about its policies.
5
GREENMetrex Rsch. Corp. v. United States, 151 F.R.D. 122 (D. Colo. 1993).
cites § 20.1 2×cited by 8 cases
Where it cites § 20.1
“Defendant also claims that Plaintiff may not depose employees of the Food and Drug Administration (FDA) without first obtaining the approval of the FDA Commissioner, citing 21 C.F.R. § 20.1 . Defendant is mistaken.”
6
GREENMatthews v. Storgion, 174 F. App'x 980 (6th Cir. 2006).
cites § 20.1 2×cited by 4 casesunpublished
Where it cites § 20.1
“They cite to 21 CFR § 20.1 (a), which forbids FDA employees, “except as authorized by the Commissioner,” from providing “any testimony .”
7
GREENMiller v. Boston Sci. Corp., 380 F. Supp. 2d 443 (D.N.J. 2005).
cites § 20.1 1×cited by 8 cases
Summary
No passage or summary on file for this case yet.
8
GREENIn re U.S. Bioscience Sec. Litig., 150 F.R.D. 80 (E.D. Pa. 1993).
cites § 20.1 3×cited by 2 cases
Where it cites § 20.1
“Legal Analysis The Government has argued, in its memorandum in support of its motion to quash, that the “FDA’s long-standing policy, codified in the agency’s regulations at 21 C.F.R. § 20.1 , is to refuse to make agency employees available to testify in litigation to which the…”
9
GREENConnaught Labs., Inc. v. SmithKline Beecham P.L.C., 7 F. Supp. 2d 477 (D. Del. 1998).
cites § 20.1 1×cited by 7 cases
Where it cites § 20.1
“SmithKline also filed an administrative request for testimony of employees involved in the pertactin research, pursuant to 21 C.F.R. § 20.1 . While the FDA produced documents, it refused to provide *479 testimony.”
10
GREENIn re Vioxx Prods. Liab. Litig., 235 F.R.D. 334 (E.D. La. 2006).
cites § 20.1 1×cited by 3 cases
Where it cites § 20.1
“In the present case, 21 C.F.R. § 20.1 is the federal regulation at issue.”
11
GREENErva Pharm., Inc. v. Am. Cyanamid Co., 755 F. Supp. 36 (D.P.R. 1991).
cites § 20.1 1×cited by 5 cases
Where it cites § 20.1
“Moreover, we note that pursuant to 21 C.F.R. § 20.1 (b), "Testimony by Food and Drug Administration employees,” the Commissioner has not authorized Mr.”
12
GREENConnaught Labs., Inc. v. Smithkline Beecham P.L.C., 165 F.3d 1368 (Fed. Cir. 1999).
cites § 20.1 1×cited by 3 cases
Where it cites § 20.1
“Maintaining that the documents provided were not sufficient for its purposes, Smith-Kline also filed a request under 21 C.F.R. § 20.1 for testimony of FDA employees involved in the pertactin research, but the FDA refused to allow the testimony.”
Later courts cite it for
“it may be used to overturn a district court order only when there has been a clear abuse of discretion or usurpation of judicial authority in the grant or denial of the order.” · 4 citing courts
13
NO FLAGHomyk v. ChemoCentryx, Inc., No. 4:21-cv-03343 (N.D. Cal. Mar. 11, 2024).
cites § 20.1 5×cited by 0 casesunknown
Where it cites § 20.1
“2 The Court’s deadline for Lead Plaintiff to file the 21 C.F.R. § 20.1 request materials was March 27 7, 2024.”
14
NO FLAGUnited States v. Specialist KEVIN J. KITMANYEN, No. ARMY 20110609 (A.C.C.A. Oct. 31, 2011).
cites § 20.1 7×cited by 0 casesunpublished
Where it cites § 20.1
“Chamblee identified herself “[a]s the Acting Director of the Division of Compliance Policy,” and as such has “been delegated authority by the [FDA] Commissioner to review requests made under 21 C.F.R. § 20.1 .” (Appendix A at 4; AE LVII at attachment 2).”
15
NO FLAGUnited States v. Xlear, No. 2:21-cv-00640 (D. Utah Sept. 18, 2023).
cites § 20.1 2×cited by 0 casesunknown
Where it cites § 20.1
“Under 21 C.F.R. § 20.1 , No officer or employee of the Food and Drug Administration …, except as authorized by the Commissioner of Food and Drugs pursuant to this section or in the discharge of his official duties under the laws administered by the Food and Drug Administration,…”
16
NEUTRALBorden Co. v. Liddy, 239 F. Supp. 289 (S.D. Iowa 1965).
cites § 20.1 1×cited by 1 case
Where it cites § 20.1
“Federal regulation, 21 CFR § 20.1 , prescribes the name of “ice cream” as a food identification for Borden’s 10% product in any sale of it in commerce, and under 21 U.”

The flag is Syfertize’s treatment of the citing case itself, not of the statute. “Where it cites” is the passage in the opinion; the holding is a summary of the whole case and may concern another point. Annotations are extracted automatically from the opinions in the Syfert caselaw corpus.

Citing cases by year
196519942024

One bar per year. Tallest: 3 cases in 1993. These are opinions in the Syfert collection, which holds more of some courts’ recent opinions than their older ones, so a rise can reflect what the collection holds and not more litigation.

By court
D.D.C.2A.C.C.A.11st Cir.16th Cir.1Fed. Cir.1N.D. Cal.1D. Colo.1D. Del.1

The 8 courts with the most citing cases, of 15 courts in all.

By subsection

Courts have not cited this section by subsection, so its cases are not split up here. The Leading cases tab lists the cases that cite it most heavily.

Enactment and amendments

Syfert holds no separate history line for this section. Where this code prints a source or history note, it appears with the text, usually at the end.

Versions

Edition shown: eCFR text as of Sept. 29, 2026. Syfert holds no earlier or later version of this section.

C.F.R. Home  |  Search C.F.R.  |  Search cases for this section  |  syfert.com